Frederic J. Brown | Afp | Getty Images DETROIT – The U.S. automotive industry has entered a new phase for all-electric vehicles: realism. The industry was euphoric about the EV segment in the early 2020s, but consumer demand never took off as much as expected and, as it fizzled, automakers Continue Reading
Visa says holiday spending rose 4.2% via AI, tech and apparel growth
U.S. consumers showed resilience this holiday season, driving retail spending up 4.2% year over year, according to preliminary data released Tuesday by Visa. The report from Visa Consulting and Analytics indicated that despite lingering economic headwinds, shoppers were still spending, particularly on technology and personal goods. The findings tracked payments Continue Reading
Stocks making the biggest moves premarket: NVO, HII, ZUN
Check out the companies making headlines before the bell. ZIM Integrated Shipping Services — The shipping services firm jumped 10% after its executives said a board is evaluating multiple competitive acquisition proposals. Novo Nordisk — The drugmaker jumped 7% in the premarket after the company’s GLP-1 pill received approval from Continue Reading
AAA says a gallon hits 4-year low as holiday travel starts
Customers at the GasWay Xpress Mart at 1120 Erie Blvd. pump gas on Wednesday, Dec. 3, 2025, in Schenectady, N.Y. Lori Van Buren | Albany Times Union | Hearst Newspapers | Getty Images Holiday road-trippers are feeling some relief at the pump this year. The average price of unleaded gasoline Continue Reading
What a Russia-Ukraine peace deal could mean for Europe’s gas supplies
Europe is pressing ahead with plans to ban Russian gas imports by the end of 2027, effectively capping Moscow’s energy future in the region and leaving a bevy of stranded assets in its wake. The dual Nord Stream 1 and 2 subsea pipelines were early casualties of Russia’s invasion of Continue Reading
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose Continue Reading
Debt, liquidity, and flagging confidence
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email It’s been over four years since Evergrande’s collapse sent shockwaves through China’s property market – and the hits keep coming. Debt, liquidity, and flagging confidence continue to loom over the sector. Elaine Yu has more on what Continue Reading
China may think it’s time to ‘rip the band-aid off’ property market
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Brian McCarthy from Macrolens says China Vanke, once viewed as a state-backed stabiliser in China’s property crisis, now appears set to follow Evergrande and Country Garden into default. With Beijing pulling back support and state banks unwilling Continue Reading
Trump says U.S. will keep the crude oil and tankers seized near Venezuela
U.S. President Donald Trump makes an announcement about the Navy’s “Golden Fleet” at Mar-a-lago in Palm Beach, Florida, U.S., December 22, 2025. Jessica Koscielniak | Reuters President Donald Trump on Monday said the U.S. will keep crude oil and tankers seized near Venezuela. “We’re going to keep it,” Trump told Continue Reading
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a Continue Reading